June 12, 2023
The AI Challenge: Balancing Open and Closed Ecosystems
Tech debates, AI included, often boil down to a tug-of-war between open and closed systems.
On one side, open allows interoperability, customization, and integration with third-party software or hardware. Champions highlight how openness promotes transparency, accountability, competition, and significant innovation. On the other side, defenders of closed systems argue that they are more stable and secure and better protect their owners’ property interests.
The debate over finding that balance is most advanced in Europe, where policymakers are moving forward with the AI Act.
Last week, two leading United States senators tipped the US AI debate between open and closed toward the latter. Senators Richard Blumenthal (D-CT) and Josh Hawley (R-MO), the two leaders of the Senate Judiciary Subcommittee on Privacy, Technology, and the Law, wrote a letter to Meta CEO Mark Zuckerberg to express concern about Meta’s public release of LLaMA, a large language model (LLM) developed in-house by the company.
Read the full article from China Talk.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko